AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $642,988 | -41.0% | 9,200 | -39.3% | 0.00% | -33.3% |
Q2 2023 | $1,089,972 | +221.3% | 15,168 | +175.8% | 0.00% | – |
Q1 2023 | $339,240 | -93.0% | 5,500 | -91.3% | 0.00% | -100.0% |
Q4 2022 | $4,859,190 | +411.5% | 63,000 | +195.8% | 0.01% | +366.7% |
Q3 2022 | $950,000 | -9.9% | 21,300 | -22.6% | 0.00% | 0.0% |
Q2 2022 | $1,054,000 | +86.5% | 27,506 | +101.3% | 0.00% | +200.0% |
Q1 2022 | $565,000 | -62.6% | 13,661 | -65.8% | 0.00% | -80.0% |
Q4 2021 | $1,511,000 | -2.1% | 40,000 | -14.6% | 0.01% | 0.0% |
Q3 2021 | $1,544,000 | +63.4% | 46,840 | +234.6% | 0.01% | +25.0% |
Q2 2021 | $945,000 | +297.1% | 13,998 | +233.3% | 0.00% | +300.0% |
Q1 2021 | $238,000 | -81.9% | 4,200 | -73.9% | 0.00% | -83.3% |
Q4 2020 | $1,312,000 | -3.6% | 16,100 | -15.7% | 0.01% | -14.3% |
Q3 2020 | $1,361,000 | -35.9% | 19,100 | -26.0% | 0.01% | -50.0% |
Q2 2020 | $2,123,000 | +674.8% | 25,800 | +454.7% | 0.01% | +600.0% |
Q1 2020 | $274,000 | -95.8% | 4,651 | -92.6% | 0.00% | -95.6% |
Q4 2019 | $6,507,000 | +6539.8% | 62,956 | +122.3% | 0.04% | +4400.0% |
Q3 2018 | $98,000 | +7.7% | 28,323 | 0.0% | 0.00% | – |
Q2 2018 | $91,000 | +31.9% | 28,323 | 0.0% | 0.00% | – |
Q1 2018 | $69,000 | – | 28,323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |